Bördekreis; Magdeburg; Sachsen-Anhalt
Location of affected unit(s):
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.10 - Manufacture of basic pharmaceutical products
Planned Job Reductions min:
Planned Job Reductions max:
Type of Restructuring:
Employment Effect Start:
Foreseen End Date:
Other Job Reduction Measures:
On 13 October 2017, the German pharmaceutical company Salutas Pharma GmbH confirmed the loss of 150 jobs at its site in Barleben due to internal restructuring. The job reduction process will take place in the first quarter of 2018. Management argues that cuts are inevitable due to a decline in sales from 10 billion pills per year to 8 billion pills per year.
Works council and management have started negotiations regarding a social plan.
As of October 2017, Salutas Pharma GmbH has 1,172 employees in Barleben.